Applied Biosystems to Webcast Presentation and Breakout Session at JPM

    Business Editors/Health/Medical Writers/Biotech Writers
    BIOWIRE2K
    JPMorgan Annual Healthcare Conference 2005

    FOSTER CITY, Calif.--(BUSINESS WIRE)--Jan. 5, 2005--Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, will webcast its presentation at the JPMorgan Annual Healthcare Conference. The live webcast is scheduled for Wednesday, January 12, 2005, at 11:30 a.m. ET. Catherine M. Burzik, President of Applied Biosystems, will provide an overview of the business with a focus on corporate strategy and new products. Additionally, the breakout session will be webcast live at 12:00 p.m. ET and is expected to end at approximately 12:30 p.m. ET.
    Interested parties may access the live webcast and replay by visiting the Investors section of the Applied Biosystems web site at http://ir.appliedbiosystems.com or the Investors & Media section of the Applera web site at www.applera.com. It is suggested that participants access the webcast 15 minutes before the start of the live webcast. The webcast replay will be archived on the Presentations page of the Investors section of each website.

    About Applera Corporation and Applied Biosystems

    Applera Corporation consists of two operating groups. The Applied Biosystems Group serves the life science industry and research community by developing and marketing instrument-based systems, consumables, software, and services. Customers use these tools to analyze nucleic acids (DNA and RNA), small molecules, and proteins to make scientific discoveries, develop new pharmaceuticals, and conduct standardized testing. Applied Biosystems is headquartered in Foster City, CA, and reported sales of $1.7 billion during fiscal 2004. The Celera Genomics Group (NYSE:CRA) is engaged principally in the discovery and development of targeted therapeutics for cancer, autoimmune and inflammatory diseases. Celera Genomics is leveraging its proteomic, bioinformatic, and genomic capabilities to identify and validate drug targets, and to discover and develop small molecule therapeutics. It is also seeking to advance therapeutic antibody and selected small molecule drug programs in collaboration with global technology and market leaders. Celera Diagnostics, a 50/50 joint venture between Applied Biosystems and Celera Genomics, is focused on discovery, development, and commercialization of diagnostic products. Information about Applera Corporation, including reports and other information filed by the company with the Securities and Exchange Commission, is available at http://www.applera.com, or by telephoning 800.762.6923. Information about Applied Biosystems is available at http://www.appliedbiosystems.com/.

    Copyright(C) 2005. Applera Corporation. All rights reserved.

--30--EB/sf*

CONTACT: Applied Biosystems Group Linda Greub, 650-554-2349 greublm@appliedbiosystems.com David Speechly, Ph.D., (+) 44.162.273.9150 (Europe) speechdp@eur.appliedbiosystems.com

KEYWORD: CALIFORNIA TRACK INDUSTRY KEYWORD: MEDICAL PHARMACEUTICAL BIOTECHNOLOGY TRADESHOW CONFERENCE CALLS SOURCE: Applied Biosystems

Copyright Business Wire 2005